Abstract:Aim: Dexibuprofen, the S (+)-isomer of ibuprofen, is an effective therapeutic agent for the treatment of neurodegenerative disorders. However, its clinical use is hampered by a limited brain distribution. The aim of this study was to design and synthesize brain-targeting dexibuprofen prodrugs and to evaluate their brain-targeting efficiency using biodistribution and pharmacokinetic analysis. Methods: In vitro stability, biodistribution and pharmacokinetic studies were performed on male Sprague-Dawley rats. The concentrations of dexibuprofen in biosamples, including the plasma, brain, heart, liver, spleen, lung, and kidney, were measured using high pressure lipid chromatography (HPLC). The pharmacokinetic parameters of the drug in the plasma and tissues were calculated using obtained data and statistics. Results: Five dexibuprofen prodrugs that were modified to contain ethanolamine-related structures were designed and synthesized. Their chemical structures were confirmed using 1 H NMR, 13 C NMR, IR, and HRMS. In the biodistribution study, 10 min after intravenous administration of dexibuprofen (11.70 mg/kg) and its prodrugs (the dose of each compound was equivalent to 11.70 mg/kg of dexibuprofen) in male Sprague-Dawley rats, the dexibuprofen concentrations in the brain and plasma were measured. The C brain / C plasma ratios of prodrugs 1, 2, 3, 4, and 5 were 17.0-, 15.7-, 7.88-, 9.31-, and 3.42-fold higher than that of dexibuprofen, respectively ( P <0.01). Thus, each of the prodrugs exhibited a significantly enhanced brain distribution when compared with dexibuprofen. In the pharmacokinetic study, prodrug 1 exhibited a brain-targeting index of 11.19 {DTI=(AUC brain /AUC plasma ) 1 /(AUC brain /AUC plasma ) dexibuprofen }. Conclusion: The ethanolamine-related structures may play an important role in transport across the brain blood barrier.

[Studies on Synthesis and Properties of N-benzoyl-THA Targeting for Brain].

[Synthesis of Prodrugs of Tacrine Hydrochloride and Evaluation of the Stability and Biodistribution in Mice].

Synthesis and Characterization of 9-[P-(n,n-dipropyl Sulfamide)] Benzoylamino-1,2,3,4-4H-acridine—A Potential Prodrug for the CNS Delivery of Tacrine

Synthesis and Targeting of Dihydropyridine Carrier-Mutual Prodrug of Tacrine

Design, Synthesis and Biological Evaluation of Brain Targeting L-Ascorbic Acid Prodrugs of Ibuprofen with "Lock-In" Function

Design, synthesis and biological evaluation of brain-specific glucosyl thiamine disulfide prodrugs of naproxen.

Novel brain-targeting 3-<i>n</i>-butylphthalide prodrugs for ischemic stroke treatment

Identification of 2-subsituted benzothiazole derivatives as triple-functional agents with potential for AD therapy

Simultaneous determination of N-butyramide-tacrine and tacrine in mouse plasma and brain homogenate by high-performance liquid chromatography with a simple gradient solvent system.

Synthesis, Biological Activity, and Biopharmaceutical Characterization of Tacrine Dimers As Acetylcholinesterase Inhibitors.

Novel brain-targeting 3-n-butylphthalide prodrugs for ischemic stroke treatment

Advances in Brain-targeting Prodrugs Based on “Lock-In” Chemical Delivery System

Multi-Target Potential Of Newly Designed Tacrine-Derived Cholinesterase Inhibitors: Synthesis, Computational And Pharmacological Study

Pyrilamine-Sensitive Proton-Coupled Organic Cation (h+/oc) Antiporter for Brain-Specific Drug Delivery

Design, Synthesis and Evaluation of Dual-targeting Prodrug Co-modified by Organic Amine and L-ascorbic Acid for CNS Delivery

Dual-targeting for brain-specific drug delivery: synthesis and biological evaluation.

Synthesis, in vitro and in vivo characterization of glycosyl derivatives of ibuprofen as novel prodrugs for brain drug delivery

Liposome Formulated with TAT-modified Cholesterol for Improving Brain Delivery and Therapeutic Efficacy on Brain Glioma in Animals

Novel ligand conjugated poly(propylene imine) dendrimers for brain targeted delivery of tacrine hydrochloride

In Vitro and in Vivo Investigation of Dexibuprofen Derivatives for CNS Delivery

Design and synthesis of Ibuprofen prodrugs for brain target delivery using D-glucose as a vector